$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 64 | 30 | 53,123 | 53.1 K to 53.1 K (+0.12 %) |
| Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 104,567 | |
| Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.23 | 4,460 | 353,366 | 0 | 4.5 K to 0 (-100.00 %) |
| Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.50 | 8,540 | 670,390 | 4,460 | 13 K to 4.5 K (-65.69 %) |
| Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 23,572 | 7,131 | 117,567 | |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 82.22 | 2,966 | 243,865 | 0 | 3 K to 0 (-100.00 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 81.40 | 11,369 | 925,437 | 2,966 | 14.3 K to 3 K (-79.31 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.35 | 9,237 | 742,193 | 14,335 | 23.6 K to 14.3 K (-39.19 %) |
| Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 23,572 | 7,131 | 23,572 | 0 to 23.6 K |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 52.29 | 2,150 | 112,424 | 12,850 | |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 75.00 | 2,150 | 161,250 | 0 | 2.2 K to 0 (-100.00 %) |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 52.29 | 2,150 | 112,424 | 2,150 | 0 to 2.2 K |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 20 | 6 | 141,139 | |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 20 | 1,600 | 0 | 20 to 0 (-100.00 %) |
| Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 20 | 6 | 20 | 0 to 20 |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 25,000 | 994,000 | 75,000 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.83 | 25,000 | 1,870,750 | 0 | 25 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 25,000 | 994,000 | 25,000 | 0 to 25 K |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,533 | 4,094 | 141,159 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 32,875 | 9,945 | 5,962 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 13,533 | 1,082,775 | 0 | 13.5 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,533 | 4,094 | 13,533 | 0 to 13.5 K |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 32,875 | 2,630,329 | 0 | 32.9 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 32,875 | 9,945 | 32,875 | 0 to 32.9 K |
| Jan 23 2018 | AGIO | AGIOS PHARMACEUTIC ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 67.00 | 851,154 | 57,027,318 | 1,374,599 | 523.4 K to 1.4 M (+162.61 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 53,000 | 16,033 | 154,692 | |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.80 | 6,597 | 493,456 | 0 | 6.6 K to 0 (-100.00 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.11 | 10,914 | 808,837 | 6,597 | 17.5 K to 6.6 K (-62.33 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 73.02 | 22,304 | 1,628,638 | 17,511 | 39.8 K to 17.5 K (-56.02 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 71.77 | 13,185 | 946,287 | 39,815 | 53 K to 39.8 K (-24.88 %) |
| Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 53,000 | 16,033 | 53,000 | 0 to 53 K |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 3,000 | 1,403 | 1,867 | |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 3,000 | 195,000 | 53,059 | 56.1 K to 53.1 K (-5.35 %) |
| Jan 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 3,000 | 1,403 | 56,059 | 53.1 K to 56.1 K (+5.65 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.45 | 631 | 38,144 | 79,515 | 80.1 K to 79.5 K (-0.79 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.45 | 631 | 38,144 | 79,475 | 80.1 K to 79.5 K (-0.79 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.68 | 288 | 17,188 | 80,146 | 80.4 K to 80.1 K (-0.36 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.68 | 288 | 17,188 | 80,106 | 80.4 K to 80.1 K (-0.36 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.01 | 204 | 12,242 | 80,434 | 80.6 K to 80.4 K (-0.25 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.01 | 204 | 12,242 | 80,394 | 80.6 K to 80.4 K (-0.25 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 58.95 | 254 | 14,973 | 80,638 | 80.9 K to 80.6 K (-0.31 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 58.95 | 253 | 14,914 | 80,598 | 80.9 K to 80.6 K (-0.31 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.90 | 542 | 31,382 | 80,892 | 81.4 K to 80.9 K (-0.67 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.90 | 543 | 31,440 | 80,851 | 81.4 K to 80.9 K (-0.67 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 31,818 | 74,375 | 31,818 | |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 102 | 48 | 4,867 | |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 14,875 | 6,954 | 0 | |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 31,818 | 74,375 | 53,059 | 21.2 K to 53.1 K (+149.80 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 102 | 48 | 21,241 | 21.1 K to 21.2 K (+0.48 %) |
| Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 14,875 | 6,954 | 21,139 | 6.3 K to 21.1 K (+237.47 %) |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Director | Option Exercise | A | 61.17 | 16,000 | 978,720 | 16,000 | |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 2,146 | 67,899 | 30,039 | |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.76 | 700 | 43,232 | 6,264 | 7 K to 6.3 K (-10.05 %) |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.63 | 846 | 51,293 | 6,964 | 7.8 K to 7 K (-10.83 %) |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 59.89 | 600 | 35,934 | 7,810 | 8.4 K to 7.8 K (-7.13 %) |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 2,146 | 67,899 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.46 | 309 | 18,682 | 81,434 | 81.7 K to 81.4 K (-0.38 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.46 | 309 | 18,682 | 81,394 | 81.7 K to 81.4 K (-0.38 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.36 | 691 | 41,018 | 81,743 | 82.4 K to 81.7 K (-0.84 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.36 | 691 | 41,018 | 81,703 | 82.4 K to 81.7 K (-0.84 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 62.07 | 1,000 | 62,070 | 82,434 | 83.4 K to 82.4 K (-1.20 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 62.07 | 1,000 | 62,070 | 82,394 | 83.4 K to 82.4 K (-1.20 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 2,146 | 67,899 | 32,185 | |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.81 | 946 | 58,472 | 6,264 | 7.2 K to 6.3 K (-13.12 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 63.09 | 900 | 56,781 | 7,210 | 8.1 K to 7.2 K (-11.10 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 63.62 | 200 | 12,724 | 8,110 | 8.3 K to 8.1 K (-2.41 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.45 | 100 | 6,545 | 8,310 | 8.4 K to 8.3 K (-1.19 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 2,146 | 67,899 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 26,656 | |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 63.32 | 4,260 | 269,743 | 0 | 4.3 K to 0 (-100.00 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 64.64 | 942 | 60,891 | 4,260 | 5.2 K to 4.3 K (-18.11 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 65.42 | 598 | 39,121 | 5,202 | 5.8 K to 5.2 K (-10.31 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 66.75 | 200 | 13,350 | 5,800 | 6 K to 5.8 K (-3.33 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
| Oct 18 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 71.10 | 1,000 | 71,100 | 83,434 | 84.4 K to 83.4 K (-1.18 %) |
| Oct 18 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 71.10 | 1,000 | 71,100 | 83,394 | 84.4 K to 83.4 K (-1.18 %) |
| Oct 18 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 71.09 | 1,000 | 71,090 | 84,434 | 85.4 K to 84.4 K (-1.17 %) |
| Oct 18 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 71.09 | 1,000 | 71,090 | 84,394 | 85.4 K to 84.4 K (-1.17 %) |
| Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 70.00 | 10,470 | 732,900 | 0 | 10.5 K to 0 (-100.00 %) |
| Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 80,000 | 24,200 | 32,656 | |
| Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 70.14 | 80,000 | 5,611,200 | 0 | 80 K to 0 (-100.00 %) |
| Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 80,000 | 24,200 | 80,000 | 0 to 80 K |
| Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 112,656 | |
| Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 66.76 | 6,000 | 400,560 | 0 | 6 K to 0 (-100.00 %) |
| Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 35,000 | 10,588 | 118,656 | |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 67.12 | 35,000 | 2,349,200 | 0 | 35 K to 0 (-100.00 %) |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 35,000 | 10,588 | 35,000 | 0 to 35 K |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Gift | G | 0.00 | 500 | 0 | 271,772 | 272.3 K to 271.8 K (-0.18 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.71 | 1,000 | 65,710 | 85,434 | 86.4 K to 85.4 K (-1.16 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.71 | 1,000 | 65,710 | 85,394 | 86.4 K to 85.4 K (-1.16 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.47 | 1,000 | 65,470 | 86,434 | 87.4 K to 86.4 K (-1.14 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.47 | 1,000 | 65,470 | 86,394 | 87.4 K to 86.4 K (-1.14 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 6,000 | 210,960 | 109,000 | |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 65.00 | 6,000 | 390,000 | 881 | 6.9 K to 881 (-87.20 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 6,000 | 210,960 | 6,881 | 881 to 6.9 K (+681.04 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 15,000 | 975,000 | 10,470 | 25.5 K to 10.5 K (-58.89 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,146 | 19,421 | 35,281 | |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.99 | 2,146 | 133,031 | 6,264 | 8.4 K to 6.3 K (-25.52 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,146 | 19,421 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 153,656 | |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.20 | 6,000 | 373,200 | 0 | 6 K to 0 (-100.00 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.07 | 500 | 28,535 | 87,434 | 87.9 K to 87.4 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.07 | 500 | 28,535 | 87,394 | 87.9 K to 87.4 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.09 | 500 | 28,545 | 87,934 | 88.4 K to 87.9 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.09 | 500 | 28,545 | 87,894 | 88.4 K to 87.9 K (-0.57 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.61 | 500 | 28,305 | 88,434 | 88.9 K to 88.4 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.61 | 500 | 28,305 | 88,394 | 88.9 K to 88.4 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.63 | 500 | 28,315 | 88,934 | 89.4 K to 88.9 K (-0.56 %) |
| Aug 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.63 | 500 | 28,315 | 88,894 | 89.4 K to 88.9 K (-0.56 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,146 | 19,421 | 37,427 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.06 | 21,000 | 1,261,260 | 25,470 | 46.5 K to 25.5 K (-45.19 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.05 | 2,146 | 118,137 | 6,264 | 8.4 K to 6.3 K (-25.52 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,146 | 19,421 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 24,000 | 7,260 | 159,656 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 183,656 | |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 60.55 | 24,000 | 1,453,200 | 0 | 24 K to 0 (-100.00 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 24,000 | 7,260 | 24,000 | 0 to 24 K |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 55.12 | 3,000 | 165,360 | 0 | 3 K to 0 (-100.00 %) |
| Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.13 | 500 | 28,565 | 85,237 | 85.7 K to 85.2 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.13 | 500 | 28,565 | 85,197 | 85.7 K to 85.2 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.12 | 500 | 28,560 | 85,737 | 86.2 K to 85.7 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.12 | 500 | 28,560 | 85,697 | 86.2 K to 85.7 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.11 | 500 | 28,055 | 86,237 | 86.7 K to 86.2 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.11 | 500 | 28,055 | 86,197 | 86.7 K to 86.2 K (-0.58 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.15 | 3,000 | 168,450 | 86,737 | 89.7 K to 86.7 K (-3.34 %) |
| Jul 21 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 56.15 | 3,000 | 168,450 | 86,697 | 89.7 K to 86.7 K (-3.34 %) |
| Jul 11 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,146 | 19,421 | 39,573 | |
| Jul 11 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.00 | 2,146 | 118,030 | 6,264 | 8.4 K to 6.3 K (-25.52 %) |
| Jul 11 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,146 | 19,421 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 186,656 | |
| Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 51.18 | 3,000 | 153,540 | 0 | 3 K to 0 (-100.00 %) |
| Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
| Jun 27 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 3,000 | 1,403 | 14,875 | |
| Jun 27 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 3,000 | 1,403 | 6,264 | 3.3 K to 6.3 K (+91.91 %) |
| Jun 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 3,000 | 1,403 | 17,875 | |
| Jun 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 4,292 | 38,843 | 41,719 | |
| Jun 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 3,000 | 1,403 | 3,264 | 264 to 3.3 K (+1,136.36 %) |
| Jun 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.00 | 4,292 | 236,060 | 264 | 4.6 K to 264 (-94.21 %) |
| Jun 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 4,292 | 38,843 | 4,556 | 264 to 4.6 K (+1,625.76 %) |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 50.73 | 9,000 | 456,570 | 9,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 50.73 | 9,000 | 456,570 | 9,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Option Exercise | A | 50.73 | 8,500 | 431,205 | 8,500 |